Article info

PDF

Review
LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes

Authors

  • Sophie N M Binks Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UKDepartment of Neurology, Oxford University Hospitals, John Radcliffe Hospital, Oxford, UK PubMed articlesGoogle scholar articles
  • Christopher J Klein Department of Neurology, Neuroimmunology Laboratory, Mayo Clinic, Rochester, Minnesota, USADepartment of Neurology, Mayo Clinic, Rochester, Minnesota, USA PubMed articlesGoogle scholar articles
  • Patrick Waters Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UKDepartment of Neurology, Oxford University Hospitals, John Radcliffe Hospital, Oxford, UK PubMed articlesGoogle scholar articles
  • Sean J Pittock Department of Neurology, Neuroimmunology Laboratory, Mayo Clinic, Rochester, Minnesota, USADepartment of Neurology, Mayo Clinic, Rochester, Minnesota, USA PubMed articlesGoogle scholar articles
  • Sarosh R Irani Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UKDepartment of Neurology, Oxford University Hospitals, John Radcliffe Hospital, Oxford, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Prof Sarosh R Irani, Autoimmune Neurology Group, John Radcliffe Hospital, Oxford OX3 9DS, UK; sarosh.irani{at}ndcn.ox.ac.uk
View Full Text

Citation

Binks SNM, Klein CJ, Waters P, et al
LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes

Publication history

  • Received 13 August 2017
  • Revised 21 September 2017
  • Accepted 22 September 2017
  • Published online 21 October 2017.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.